Home » Topics » BioWorld Science

BioWorld Science
RSS

NIMIUM and Paraza partner to develop G3PP activators to treat cardiometabolic diseases

July 21, 2021

First participants dosed in phase Ib/IIa FOCUSC9 study of WVE-004

July 21, 2021

Latvian Institute of Organic Synthesis discloses tubulin polymerization inhibitors

July 21, 2021

Wigen Biomedicine Technology presents GTPase KRAS mutant inhibitors

July 21, 2021

Tecnimede-Sociedade Tecnico-Medicinal discloses compounds for tuberculosis

July 21, 2021

Medshine Discovery patents new compounds for NASH

July 21, 2021

Dosing begins in phase I study of HLX-04-O in China

July 21, 2021

Lethal autoinflammatory syndrome linked to loss-of-function C2orf69 gene variants

July 21, 2021

Biodegradable polymeric solid implants developed for long-acting HIV pre-exposure prophylaxis

July 21, 2021

Celgene opens enrollment in phase I study of CC-90011 in metastatic CRPC

July 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...